The Icahn School of Medicine at Mount Sinai is among the top 10 research institutions in the world based on its contributions to published research that is later cited by other organizations in patent development. The rankings, created by the Nature Index 2017 Innovation supplement and published in August, used a unique set of metrics to shed light on the impact academic research is having on innovation and determine key academic players whose ideas may shape tomorrow’s inventions.
According to the Nature Index, the top rankings reflect institutions with global reputations for high-quality research and others whose published work is having a disproportionately high impact relative to their size.
The Scripps Research Institute in San Diego (No. 1), Rockefeller University in New York City (No. 2), and Massachusetts Institute of Technology (No. 3) led the list, which also included, among others, “U.S. research heavyweights—the National Institutes of Health (No. 7), University of California, San Francisco (No. 8), and Stanford University (No. 9),” a press release issued by the publication said, adding, “Icahn School of Medicine at Mount Sinai is notably placed tenth.”
“Our ranking among the top 10 most influential research institutions in the world reflects our longstanding culture of innovation; our commitment to recruiting accomplished scientists, students, and executives who can advance biomedical innovation and discovery; as well as our transformative approach to discovery to produce radically better outcomes for patients,” says Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai, and President for Academic Affairs of the Mount Sinai Health System. “We are proud to be recognized for the profound influence our science is having on medical discovery around the world.”
Said David Swinbanks, founder of the Nature Index, in a press release: “This analysis comes at a time when following the transfer of scientific knowledge into industry and the economy is a growing priority for governments and research funding agencies. For them, the need to demonstrate that publicly funded science is being used for society’s benefit is paramount.”
The index was compiled by Nature Research, a unit of the company that publishes the journal Nature.